13G Filing: Birchview Capital and Soleno Therapeutics Inc (SLNO)

Page 2 of 4 – SEC Filing

CUSIP NO. 834203200 Page 2 of 4 Pages
CUSIP No.  834203200
(1) Names of reporting persons Birchview Capital, LP
(2) Check the appropriate box if a member of a group (a)
(see instructions) (b)
(3) SEC use only
(4) Citizenship or place of organization DE
Number of shares beneficially owned by each reporting person with:
(5) Sole voting power 1,180,463
(6) Shared voting power 0
(7) Sole dispositive power 1,180,463
(8) Shared dispositive power 0
(9) Aggregate amount beneficially owned by each reporting person 1,180,463
(10) Check if the aggregate amount in Row (9) excludes certain shares (see instructions)
(11) Percent of class represented by amount in Row (9) 6.166%
(12) Type of reporting person (see instructions) IA

 

Item 1(a). Name of Issuer:
SOLENO THERAPEUTICS, INC. (the “Issuer”).
Item 1(b). Address of the Issuer’s Principal Executive Offices:
1235 Radio Road, Suite 110, Redwood City, CA 94065.
Item 2(a). Name of Person Filing
Birchview Capital, LP (the “Reporting Person”).
Item 2(b). Address of Principal Business Office or, if None, Residence:
688 Pine Street, Suite D, Burlington, VT 05401.
Item 2(c). Citizenship:
The Reporting Person is a Delaware limited partnership.
Item 2(d).

Title of Class of Securities:

Common Stock (the “Shares”) and Warrants for Common Stock (the “Warrants”).
Item 2(e). CUSIP Number:
834203200

Follow Soleno Therapeutics Inc (NASDAQ:SLNO)